APA (7th ed.) Citation

Wang, J., Yao, W., Wang, W., Fan, M., Huang, K., Liu, Z., & Zhu, D. (2023). Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: A case report. Frontiers in oncology, 13, 1164543. https://doi.org/10.3389/fonc.2023.1164543

Chicago Style (17th ed.) Citation

Wang, Jiantao, Wenqing Yao, Weiya Wang, Mingyu Fan, Kaili Huang, Zhenkun Liu, and Daxing Zhu. "Complete Pathological Response and Negative Postoperative CtDNA Were Not Predictive of Discontinuation of Adjuvant Crizotinib Therapy in a Patient with Locally Advanced MET Ex14 Skipping Mutation-positive Non-small Cell Lung Cancer: A Case Report." Frontiers in Oncology 13 (2023): 1164543. https://doi.org/10.3389/fonc.2023.1164543.

MLA (9th ed.) Citation

Wang, Jiantao, et al. "Complete Pathological Response and Negative Postoperative CtDNA Were Not Predictive of Discontinuation of Adjuvant Crizotinib Therapy in a Patient with Locally Advanced MET Ex14 Skipping Mutation-positive Non-small Cell Lung Cancer: A Case Report." Frontiers in Oncology, vol. 13, 2023, p. 1164543, https://doi.org/10.3389/fonc.2023.1164543.